Contact
searchSearch
HMP Global

Pharmacy Learning Network

PharmLaw

PharmLaw
West Virginia Files Lawsuit Alleging Optum’s PBM Practices Contributed to Opioid Crisis
12/10/2025
Danielle Sposato
West Virginia has sued Optum, alleging the PBM’s rebate-driven formulary practices, manufacturer collaborations, data sharing, mail-order dispensing, and discount card programs contributed to the state’s opioid crisis. The lawsuit seeks...
West Virginia has sued Optum, alleging the PBM’s rebate-driven formulary practices, manufacturer collaborations, data sharing, mail-order dispensing, and discount card programs contributed to the state’s opioid crisis. The lawsuit seeks...
West Virginia has sued Optum,...
12/10/2025
Pharmacy Learning Network
PharmLaw
CVS to Pay $37.76 Million to Resolve Federal Allegations of Over-Dispensing Insulin Pens
12/05/2025
Danielle Sposato
The US Attorney’s Office for the Southern District of New York has announced a $37.76 million settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated the False Claims Act by over-dispensing insulin pens and...
The US Attorney’s Office for the Southern District of New York has announced a $37.76 million settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated the False Claims Act by over-dispensing insulin pens and...
The US Attorney’s Office for the...
12/05/2025
Pharmacy Learning Network
PharmLaw
FTC Action Against Caremark & Zinc Health Services Sparks Proposed Regulatory Overhaul of Insulin Pricing Practices
11/26/2025
Danielle Sposato
The Federal Trade Commission’s enforcement action against Caremark Rx, LLC, Zinc Health Services, LLC, and related entities—which centers on how pharmacy benefit managers (PBMs) and their affiliated group purchasing organizations (GPOs)...
The Federal Trade Commission’s enforcement action against Caremark Rx, LLC, Zinc Health Services, LLC, and related entities—which centers on how pharmacy benefit managers (PBMs) and their affiliated group purchasing organizations (GPOs)...
The Federal Trade Commission’s...
11/26/2025
Pharmacy Learning Network
PharmLaw
Purdue Pharma Bankruptcy Plan Approved: $7.4 Billion Settlement Marks Turning Point in Opioid Accountability
11/18/2025
Danielle Sposato
NEW YORK — In a major step toward resolving one of the most consequential public health lawsuits in U.S. history, US Bankruptcy Judge Sean Lane has approved Purdue Pharma’s bankruptcy plan, finalizing a $7.4 billion settlement between the...
NEW YORK — In a major step toward resolving one of the most consequential public health lawsuits in U.S. history, US Bankruptcy Judge Sean Lane has approved Purdue Pharma’s bankruptcy plan, finalizing a $7.4 billion settlement between the...
NEW YORK — In a major step...
11/18/2025
Pharmacy Learning Network
Latner Headshot
PharmLaw
Pharmacy Owner and 3 Pharmacists Sentence to Prison for Pill Mill Scheme
10/28/2025
Ann W. Latner, JD
Four Texas pharmacists, including one pharmacy owner, have been sentenced to prison for unlawful distribution of more than half a million opioid pills and other prescription drugs.
Four Texas pharmacists, including one pharmacy owner, have been sentenced to prison for unlawful distribution of more than half a million opioid pills and other prescription drugs.
Four Texas pharmacists,...
10/28/2025
Pharmacy Learning Network

FDA Recalls

News
Quality Control Concerns Prompt Recall of Lanashield Skin Barrier by Blossom Pharmaceuticals
12/11/2025
Juliet Gallagher
A nationwide Class II recall has been initiated for Lanashield Skin Barrier, a 4 oz. (113 g) topical product manufactured for Dynarex Corporation. The recall includes 3 lots—A162301 (exp. 9/26), A162401 (exp. 4/27), and A162202 (exp....
A nationwide Class II recall has been initiated for Lanashield Skin Barrier, a 4 oz. (113 g) topical product manufactured for Dynarex Corporation. The recall includes 3 lots—A162301 (exp. 9/26), A162401 (exp. 4/27), and A162202 (exp....
A nationwide Class II recall has...
12/11/2025
Pharmacy Learning Network
News
Haloperidol Injection Recalled After Incorrect RFID Tags Applied by Repackager
12/11/2025
Juliet Gallagher
A voluntary Class II recall has been initiated for haloperidol lactate injection, 5 mg/mL, packaged in 25 x 1 mL single-dose sterile vials and manufactured for Mylan Institutional LLC.
A voluntary Class II recall has been initiated for haloperidol lactate injection, 5 mg/mL, packaged in 25 x 1 mL single-dose sterile vials and manufactured for Mylan Institutional LLC.
A voluntary Class II recall has...
12/11/2025
Pharmacy Learning Network
News
Class II Recall Issued for Phenylephrine Syringes Due to CGMP Compliance Failures
12/11/2025
Juliet Gallagher
A voluntary Class II recall has been issued for phenylephrine HCl injection, 1000 mcg/10 mL, manufactured and distributed by Park Avenue Compounding of Saint Louis, Missouri.
A voluntary Class II recall has been issued for phenylephrine HCl injection, 1000 mcg/10 mL, manufactured and distributed by Park Avenue Compounding of Saint Louis, Missouri.
A voluntary Class II recall has...
12/11/2025
Pharmacy Learning Network
News
Actavis Testosterone Gel Recalled for Defect
12/04/2025
The US Food and Drug Administration (FDA) has issued a recall for Actavis Testosterone Gel due to a packet side‑seal defect that can cause product leakage, potentially affecting dose delivery and increasing risk of accidental exposure.
The US Food and Drug Administration (FDA) has issued a recall for Actavis Testosterone Gel due to a packet side‑seal defect that can cause product leakage, potentially affecting dose delivery and increasing risk of accidental exposure.
The US Food and Drug...
12/04/2025
Pharmacy Learning Network
News
Class II Recall for Cipla’s Phytonadione Injection
12/04/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Cipla’s Phytonadione Injectable Emulsion (Vitamin K1) due to out-of-specification stability results.
The US Food and Drug Administration (FDA) has issued a Class II recall for Cipla’s Phytonadione Injectable Emulsion (Vitamin K1) due to out-of-specification stability results.
The US Food and Drug...
12/04/2025
Pharmacy Learning Network

In the News

News
Quality Control Concerns Prompt Recall of Lanashield Skin Barrier by Blossom Pharmaceuticals
12/11/2025
Juliet Gallagher
A nationwide Class II recall has been initiated for Lanashield Skin Barrier, a 4 oz. (113 g) topical product manufactured for Dynarex Corporation. The recall includes 3 lots—A162301 (exp. 9/26), A162401 (exp. 4/27), and A162202 (exp....
A nationwide Class II recall has been initiated for Lanashield Skin Barrier, a 4 oz. (113 g) topical product manufactured for Dynarex Corporation. The recall includes 3 lots—A162301 (exp. 9/26), A162401 (exp. 4/27), and A162202 (exp....
A nationwide Class II recall has...
12/11/2025
Pharmacy Learning Network
News
Haloperidol Injection Recalled After Incorrect RFID Tags Applied by Repackager
12/11/2025
Juliet Gallagher
A voluntary Class II recall has been initiated for haloperidol lactate injection, 5 mg/mL, packaged in 25 x 1 mL single-dose sterile vials and manufactured for Mylan Institutional LLC.
A voluntary Class II recall has been initiated for haloperidol lactate injection, 5 mg/mL, packaged in 25 x 1 mL single-dose sterile vials and manufactured for Mylan Institutional LLC.
A voluntary Class II recall has...
12/11/2025
Pharmacy Learning Network
News
Class II Recall Issued for Phenylephrine Syringes Due to CGMP Compliance Failures
12/11/2025
Juliet Gallagher
A voluntary Class II recall has been issued for phenylephrine HCl injection, 1000 mcg/10 mL, manufactured and distributed by Park Avenue Compounding of Saint Louis, Missouri.
A voluntary Class II recall has been issued for phenylephrine HCl injection, 1000 mcg/10 mL, manufactured and distributed by Park Avenue Compounding of Saint Louis, Missouri.
A voluntary Class II recall has...
12/11/2025
Pharmacy Learning Network
PharmLaw
West Virginia Files Lawsuit Alleging Optum’s PBM Practices Contributed to Opioid Crisis
12/10/2025
Danielle Sposato
West Virginia has sued Optum, alleging the PBM’s rebate-driven formulary practices, manufacturer collaborations, data sharing, mail-order dispensing, and discount card programs contributed to the state’s opioid crisis. The lawsuit seeks...
West Virginia has sued Optum, alleging the PBM’s rebate-driven formulary practices, manufacturer collaborations, data sharing, mail-order dispensing, and discount card programs contributed to the state’s opioid crisis. The lawsuit seeks...
West Virginia has sued Optum,...
12/10/2025
Pharmacy Learning Network
PharmLaw
CVS to Pay $37.76 Million to Resolve Federal Allegations of Over-Dispensing Insulin Pens
12/05/2025
Danielle Sposato
The US Attorney’s Office for the Southern District of New York has announced a $37.76 million settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated the False Claims Act by over-dispensing insulin pens and...
The US Attorney’s Office for the Southern District of New York has announced a $37.76 million settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated the False Claims Act by over-dispensing insulin pens and...
The US Attorney’s Office for the...
12/05/2025
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use